Editor’s Choice
[#item_full_content]
Hi, what are you looking for?
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
Clark Packard Last week, dozens of members of the House Republican Study Committee introduced the Countering Communist China Act (CCCA), which would, among other...
[#item_full_content]
Jeffrey A. Singer The Food and Drug Administration will delay a decision to allow Eli Lilly and Company to market its new drug, donanemab. Clinical...